Patricia Garton, APRN
Family · Norwalk, CTNPI 1750400396
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 560 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 29 manufacturers reported payments, led by Viiv Healthcare Company at 39.0% of the total. Among family clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 560 payments — averaging $27.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$6K
- Gilead$3K
- Theratechnologies Inc.$1K
- AstraZeneca$953
- Merck$852
- Johnson & Johnson$822
- plus $3K from 23 others
What the payments were for
- Food & beverage$15,46399%
- Education$2101%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 235 | $6,113 |
| Gilead | 80 | $2,710 |
| Theratechnologies Inc. | 30 | $1,010 |
| AstraZeneca | 32 | $953 |
| Merck | 36 | $852 |
| Johnson & Johnson(2 entities) | 42 | $822 |
| AbbVie | 31 | $780 |
| Abbott | 4 | $488 |
| Boehringer Ingelheim | 5 | $274 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $205 |
| Pfizer | 11 | $203 |
| Janssen Products, LP | 2 | $182 |
| Idorsia Pharmaceuticals US Inc | 4 | $168 |
| Antares Pharma, Inc. | 7 | $166 |
| Novo Nordisk | 1 | $125 |
| Bausch Health US, LLC | 5 | $109 |
| Janssen Scientific Affairs, LLC | 3 | $87 |
| EMD Serono, Inc. | 5 | $84 |
| Exact Sciences | 4 | $79 |
| Amarin Pharma, Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $47 |
| Hologic Sales And Service, LLC | 1 | $34 |
| Halozyme Inc | 1 | $25 |
| Napo Pharmaceuticals Inc | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Acerus Pharmaceuticals Corporation | 1 | $18 |
| Bristol Myers Squibb | 1 | $17 |
| Echosens North America, Inc. | 1 | $14 |
| Endo Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,674 in reported general payments places this provider in the 95th percentile of 1,596 family providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| DovatoDolutegravir Sodium/Lamivudine | 91 | $251,615 |
| JulucaDolutegravir/Rilpivirine | 62 | $201,221 |
| Egrifta SvTesamorelin Acetate | 26 | $170,876 |
| SymtuzaDarunavir/Cob/Emtri/Tenof Alaf | 25 | $110,739 |
| DescovyEmtricitabine/Tenofov Alafenam | 43 | $87,419 |
| OzempicSemaglutide | 74 | $66,380 |
| VraylarCariprazine Hcl | 37 | $50,221 |
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 14 | $49,294 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 14 | $47,659 |
| XifaxanRifaximin | 12 | $36,034 |
| TivicayDolutegravir Sodium | 13 | $27,980 |
| PrezcobixDarunavir/Cobicistat | 11 | $25,651 |
| FarxigaDapagliflozin Propanediol | 40 | $24,067 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 31 | $21,226 |
| JardianceEmpagliflozin | 21 | $15,843 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Viiv Healthcare CompanyDovato, Juluca, Tivicay | $6,113 | $480,816166 claims |
| Theratechnologies Inc.Egrifta Sv | $1,010 | $170,87626 claims |
| GileadDescovy, Biktarvy | $2,710 | $136,71357 claims |
| Janssen Products, LPSymtuza | $182 | $110,73925 claims |
| Novo NordiskOzempic | $125 | $66,38074 claims |
| AbbVieVraylar, Viibryd, Synthroid | $780 | $60,02288 claims |
| Boehringer IngelheimSynjardy Xr, Jardiance | $274 | $37,06952 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $205 | $36,03412 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Seroquel | $953 | $35,93365 claims |
| Johnson & JohnsonPrezcobix | $822 | $25,65111 claims |
| PfizerEliquis | $203 | $7,84214 claims |
| MerckJanuvia | $852 | $5,94111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,596 family providers in Connecticut.
Other family in Norwalk
- Carla ReynoldsNorwalk$10K
- Elisha ChristiansonWaterbury$371K
- Kathryn TierneyNew Britain$140K
- Jennifer SilvaSouth Windsor$91K
- Carli WillardEnfield$74K
- Erin MartinMilford$70K
- Dayna GiordanoNew Haven$65K
- Diana BytyqiDerby$53K
- Farhiya AbdiSouth Windsor$30K
- Nicole SandilandsBridgeport$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.